of the amount made available under this heading, $4,000,000,000 shall be for a vaccination campaign, including preparedness, operations, and distribution, and a comprehensive campaign to achieve coverage goals, and for an enhanced influenza vaccination campaign, including purchase of vaccine as necessary to increase coverage: Provided further , That the Director of the Centers for Disease Control and Prevention shall provide a briefing to the Committees on Appropriations of the House of Representatives and the Senate at least 1 week prior to obligating funds made available in the preceding proviso on the CDC’s plans for vaccination campaigns in fiscal year 2021: Provided further , That of the amount made available under this heading, $400,000,000 shall be for public health data surveillance and analytics infrastructure modernization: Provided further , That of the amount made available under this heading, $200,000,000 shall be for activities to support public health workforce development, including the Epidemic Intelligence Service fellowship program: Provided further , That of the amount made available under this heading, $400,000,000 shall be transferred to and merged with amounts in the Infectious Diseases Rapid Response Reserve Fund, established by section 231 of division B of Public Law 115–245 : Provided further , That such amount is designated by the Congress as being for an emergency requirement pursuant to section 251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Control Act of 1985. National Institutes of Health OFFICE OF THE DIRECTOR (INCLUDING TRANSFER OF FUNDS) For an additional amount for ‘‘Office of the Director’’, $5,000,000,000, to remain available until September 30, 2025: Provided , That funds made available under this heading may be used to offset the costs related to reductions in laboratory productivity resulting from interruptions or shutdowns of research activity in fiscal year 2020: Provided further , That funds made available under this heading may be transferred to the